Drug lookup
Drug reference

avibactam

β-Lactamase Inhibitor · β-Lactamase Inhibitor (Co-formulated with β-lactam antibiotics)

β-Lactamase Inhibitorβ-Lactamase Inhibitor (Co-formulated with β-lactam antibiotics)
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Avibactam is a novel, structurally dissimilar non–β-lactam β-lactamase inhibitor with a broader spectrum of inhibition. It provides clinically useful inhibition against narrow- and extended-spectrum β-lactamase (ESBL)-type, chromosomal AmpC, and KPC-type β-lactamases (but not metallo-β-lactamases).

Related guidelines

Other β-Lactamase Inhibitor drugs

Ask House about avibactam

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team